MTHFR and hyperhomocysteinemia: The first results in a thermolabile form of MTHFR with a reduced enzyme activity (30% of wild-type activity for TT carriers) and hyperhomocysteinemia, and increased toxicity of MTX has been associated with such a polymorphism [95].